ARCT R&D Expenses

Arcturus Therapeutics Holdings Inc · R&D Expenses

ARCT logo

ARCT R&D Expenses

Latest reported$86.18M
ARCT R&D Expenses ($1.82M → $86.18M)
High-resolution chart · PNG

ARCT r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcturus Therapeutics Holdings Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
112,212,000
195,156,000
192,133,000
147,751,000
173,760,000
57,846,000
33,640,000
16,982,000
15,918,000
18,391,000
13,461,000
25,105,000
7,066,000
818,000
1,822,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.